Regulatory Resources for Clinical Research during the COVID19 Pandemic
Provided are several resources that readers should review regarding the conduct of clinical research during the COVID19 pandemic.
· Letter from Dr Ruth O’Hara regarding continuity of clinical research at Stanford
· FDA guidance “Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic”
· Stanford IRB guidance
· Stanford Guidance for the Research Environment
· Latest Stanford Updates
Stay healthy!